News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
829,494 Results
Type
Article (75353)
Company Profile (677)
Press Release (753443)
Multimedia
Podcasts (162)
Webinars (28)
Section
Business (227106)
Career Advice (3731)
Deals (39259)
Drug Delivery (136)
Drug Development (89324)
Employer Resources (203)
FDA (17984)
Job Trends (17152)
News (387391)
Policy (38843)
Tag
Academia (3004)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56006)
ALS (145)
Alzheimer's disease (1679)
Antibody-drug conjugate (ADC) (233)
Approvals (18000)
Artificial intelligence (450)
Autoimmune disease (71)
Automation (25)
Bankruptcy (403)
Best Places to Work (12632)
BIOSECURE Act (23)
Biosimilars (159)
Biotechnology (443)
Bladder cancer (125)
Brain cancer (52)
Breast cancer (480)
Cancer (3847)
Cardiovascular disease (338)
Career advice (3190)
Career pathing (38)
CAR-T (244)
CDC (57)
Cell therapy (663)
Cervical cancer (32)
Clinical research (73932)
Collaboration (1375)
Company closure (4)
Compensation (934)
Complete response letters (59)
COVID-19 (2953)
CRISPR (81)
C-suite (585)
Cystic fibrosis (134)
Data (4343)
Decentralized trials (2)
Denatured (55)
Depression (109)
Diabetes (449)
Diagnostics (7084)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (201)
Drug pricing (189)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (95568)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (131660)
Executive appointments (987)
FDA (20415)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1239)
Gene editing (173)
Generative AI (39)
Gene therapy (538)
GLP-1 (1014)
Government (5335)
Grass and pollen (7)
Guidances (339)
Healthcare (20917)
HIV (47)
Huntington's disease (37)
IgA nephropathy (56)
Immunology and inflammation (239)
Immuno-oncology (20)
Indications (53)
Infectious disease (3187)
Inflammatory bowel disease (186)
Inflation Reduction Act (15)
Influenza (94)
Intellectual property (187)
Interviews (729)
IPO (17828)
IRA (59)
Job creations (4951)
Job search strategy (2596)
Kidney cancer (14)
Labor market (77)
Layoffs (636)
Leadership (33)
Legal (9924)
Liver cancer (91)
Longevity (12)
Lung cancer (551)
Lymphoma (264)
Machine learning (28)
Management (66)
Manufacturing (623)
MASH (138)
Medical device (14848)
Medtech (14871)
Mergers & acquisitions (22303)
Metabolic disorders (1145)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (225)
Neuropsychiatric disorders (60)
Neuroscience (2703)
NextGen: Class of 2025 (7640)
Non-profit (5095)
Now hiring (57)
Obesity (555)
Opinion (311)
Ovarian cancer (128)
Pain (164)
Pancreatic cancer (168)
Parkinson's disease (240)
Partnered (28)
Patents (415)
Patient recruitment (308)
Peanut (57)
People (64886)
Pharmaceutical (133)
Pharmacy benefit managers (27)
Phase I (22832)
Phase II (32238)
Phase III (24297)
Pipeline (2698)
Policy (294)
Postmarket research (3250)
Preclinical (10079)
Press Release (72)
Prostate cancer (195)
Psychedelics (52)
Radiopharmaceuticals (281)
Rare diseases (665)
Real estate (7150)
Recruiting (78)
Regulatory (27167)
Reports (65)
Research institute (2683)
Resumes & cover letters (581)
Rett syndrome (16)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (207)
Series B (156)
Service/supplier (26)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (40)
Startups (4214)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (95)
The Weekly (105)
Vaccines (1036)
Venture capital (66)
Weight loss (394)
Women's health (55)
Worklife (21)
Date
Last 7 days (547)
Last 30 days (2231)
Last 365 days (32643)
2025 (25643)
2024 (37893)
2023 (42567)
2022 (53927)
2021 (58722)
2020 (57663)
2019 (51303)
2018 (39085)
2017 (36802)
2016 (37710)
2015 (43699)
2014 (38332)
2013 (34274)
2012 (36222)
2011 (36275)
2010 (35624)
Location
Africa (1195)
Alabama (80)
Alaska (7)
Arizona (278)
Arkansas (14)
Asia (49380)
Australia (8464)
California (9381)
Canada (2847)
China (886)
Colorado (400)
Connecticut (417)
Delaware (260)
Europe (111743)
Florida (1385)
Georgia (315)
Hawaii (3)
Idaho (66)
Illinois (789)
India (50)
Indiana (458)
Iowa (19)
Japan (313)
Kansas (123)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1271)
Massachusetts (7064)
Michigan (309)
Minnesota (558)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (107)
New Hampshire (76)
New Jersey (2605)
New Mexico (32)
New York (2559)
North Carolina (1401)
North Dakota (10)
Northern California (4232)
Ohio (293)
Oklahoma (22)
Oregon (48)
Pennsylvania (1956)
Puerto Rico (19)
Rhode Island (46)
South America (1564)
South Carolina (49)
South Dakota (1)
Southern California (3593)
Tennessee (148)
Texas (1459)
United States (34649)
Utah (281)
Virginia (246)
Washington D.C. (83)
Washington State (808)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
829,494 Results for "lifetech scientific shenzhen co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased
September 1, 2025
·
9 min read
Press Releases
LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%
March 31, 2025
·
10 min read
Press Releases
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
October 1, 2025
·
6 min read
Press Releases
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
September 15, 2025
·
5 min read
Press Releases
NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets
September 10, 2025
·
8 min read
LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development
LifeTech Scientific Corporation, a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiaries announced the audited consolidated results for the year ended 31 December 2023.
April 2, 2024
·
13 min read
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce Collaboration to Develop Herpes Vaccines in China
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. announced they have reached an agreement to jointly develop, manufacture, and commercialize live vaccines against herpes simplex viruses.
October 30, 2023
·
2 min read
Press Releases
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
August 12, 2025
·
6 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Business
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results
LifeTech Scientific Corporation announced the unaudited consolidated results of the Company and its subsidiaries for the six months ended 30 June 2023.
August 30, 2023
·
7 min read
1 of 82,950
Next
